Literature DB >> 25981897

Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients.

Patricia J Hollen1, Pavlos Msaouel, Richard J Gralla.   

Abstract

Identifying key issues for patients is central to assessing treatment for cancer, especially when evaluating health-related quality of life (QL) and patient-reported outcomes (PROs). This study was conducted to provide enhanced content validity support by incorporating the views of a large number of patients with breast cancer. This methodological study used an anonymous, cross-sectional, electronic web-based survey of 1072 patients with a diagnosis of breast cancer. Patients ranked the importance of 21 issues on a 5-point scale. Issues included general, physical, functional, psychosocial, and summative items. Analysis was also performed by four key factors (age group, time since diagnosis, adjuvant treatment or not, and tumor extent). All of the top five issues rated as either "very important" or "important" were global issues-rather than symptoms-such as maintaining quality of life (ranked in these two highest categories by 99 % of patients), maintaining independence (97 %), and ability to perform normal activities (97 %). The abilities to concentrate and to be able to sleep (97 and 96 %, respectively) were ranked above specific breast cancer symptoms. Specific symptoms included within the top ten highest ranked items were fatigue, depression, anxiety, shortness of breath, and pain. This is the largest analysis of evidence-based data determining support for content validity for QL and PROs provided by patients with breast cancer. While symptoms are important to patients, the survey also demonstrates that PRO measures that only evaluate symptoms are not fully responding to patient-expressed needs. These results provide confidence in the content of quality of life measures for large groups of patients with breast cancer, including the new Breast Cancer Symptom Scale (BCSS) questionnaire.

Entities:  

Mesh:

Year:  2015        PMID: 25981897     DOI: 10.1007/s10549-015-3420-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  15 in total

1.  Physical Activity and Sleep Quality in Breast Cancer Survivors: A Randomized Trial.

Authors:  Laura Q Rogers; Kerry S Courneya; Robert A Oster; Philip M Anton; Randall S Robbs; Andres Forero; Edward McAuley
Journal:  Med Sci Sports Exerc       Date:  2017-10       Impact factor: 5.411

2.  Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.

Authors:  Peter A Kaufman; Masakazu Toi; Patrick Neven; Joohyuk Sohn; Eva-Maria Grischke; Valerie Andre; Clemens Stoffregen; Sarah Shekarriz; Gregory L Price; Gebra Cuyun Carter; George W Sledge
Journal:  Oncologist       Date:  2019-10-24

3.  Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial.

Authors:  Laura Q Rogers; Kerry S Courneya; Philip M Anton; Steven Verhulst; Sandra K Vicari; Randall S Robbs; Edward McAuley
Journal:  Psychooncology       Date:  2016-09-06       Impact factor: 3.894

4.  A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.

Authors:  Heather S L Jim; Aasha I Hoogland; Hyo Sook Han; Eva Culakova; Charles Heckler; Michelle Janelsins; Geoffrey C Williams; Julienne Bower; Stephen Cole; Zeruesenay Desta; Margarita Bobonis Babilonia; Gary Morrow; Luke Peppone
Journal:  Contemp Clin Trials       Date:  2020-03-05       Impact factor: 2.226

5.  Patient reported cosmetic outcome after vacuum assisted excision of benign breast lesions: a cross-sectional study.

Authors:  Elles M F van de Voort; Taco M A L Klem; Gerson M Struik; Erwin Birnie; Renata H J A Sinke; Ali Ghandi
Journal:  Br J Radiol       Date:  2020-07-20       Impact factor: 3.039

6.  Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial.

Authors:  Patricia Lindberg; Michael Koller; Brunhilde Steinger; Wilfried Lorenz; Jeremy C Wyatt; Elisabeth C Inwald; Monika Klinkhammer-Schalke
Journal:  BMC Cancer       Date:  2015-07-29       Impact factor: 4.430

7.  Integration of Massage Therapy in Outpatient Cancer Care.

Authors:  Virginia S Cowen; Barbara Tafuto
Journal:  Int J Ther Massage Bodywork       Date:  2018-03-26

8.  Changes in Body Mass Index and Physical Activity Predict Changes in Vitality During a Weight Loss Trial in Breast Cancer Survivors.

Authors:  Kelly M Kenzik; Wendy Demark-Wahnefried; Patricia A Ganz; Graham Colditz; Cheryl L Rock; Laura Q Rogers
Journal:  Ann Behav Med       Date:  2018-11-12

9.  Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.

Authors:  N Harbeck; S Iyer; N Turner; M Cristofanilli; J Ro; F André; S Loi; S Verma; H Iwata; H Bhattacharyya; K Puyana Theall; C H Bartlett; S Loibl
Journal:  Ann Oncol       Date:  2016-03-30       Impact factor: 32.976

10.  Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countries.

Authors:  Alison Davie; Gebra Cuyun Carter; Alex Rider; James Pike; Katie Lewis; Abigail Bailey; Gregory L Price; Francois Ringeisen; Xavier Pivot
Journal:  BMC Cancer       Date:  2020-09-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.